GLP-3 RT 10mg: Triple Agonist

GLP-3 RT is an investigational triple-agonist peptide designed to simultaneously activate GLP-1, GIP, and Glucagon receptors. This unique multi-receptor activity has made GLP-3 RT one of the most studied next-generation metabolic research peptides in preclinical and early clinical development models.

It is researched primarily for its effects on energy balance, metabolic regulation, and adipose tissue signaling.

Scientific Background

GLP-3 RT is a synthetic 39-amino-acid peptide engineered to act as a potent agonist of:

GLP-1 receptor – involved in glucose regulation, appetite signaling, and gastric emptying

GIP receptor – associated with insulin release and metabolic sensitivity

Glucagon receptor – influences energy expenditure and fat mobilization

By engaging all three pathways simultaneously, GLP-3 represents a new class of triple-hormone receptor agonists.

Research Areas of Interest

All information below is strictly intended for laboratory, scientific, and in-vitro research discussion only.

1. Metabolic Regulation

GLP-3 RT is studied for its ability to influence:

Energy balance

Glucose handling

Insulin sensitivity

Hormonal signaling in metabolic tissues

2. Body-Weight Research Models

Due to its multi-receptor activity, research models evaluate potential effects on:

Appetite signaling

Energy expenditure

Lipolysis and fat mobilization

3. GLP-1 + GIP + Glucagon Synergy

GLP-3 RT’s triple-agonist mechanism allows researchers to assess:

Combined incretin activity

Crosstalk between glucagon and insulin pathways

Multi-pathway metabolic switching

4. Adipose & Liver Tissue Studies

Investigative models explore potential roles in:

Fatty-acid oxidation

Hepatic glucose output

Adipose tissue remodeling

5. Next-Generation Incretin Research

GLP-3 RT is part of a broader category of advanced incretin-based research peptides including:

GLP-2 (dual GLP-1/GIP agonist)

Cagrilintide (amylin analogue)

Semaglutide (GLP-1 agonist)

GLP-3 RT’s triple-agonist profile makes it a unique tool for studying combination hormone activity.

Molecular Profile

Peptide: GLP-3 RT

Type: GLP-1/GIP/Glucagon Triple-Receptor Agonist

Sequence Length: 39 amino acids (synthetic analogue)

Form: Lyophilized powder

Purity: ≥ 98% (HPLC tested)

Exact full amino-acid sequence is typically proprietary in pharmaceutical development and not publicly displayed by peptide vendors.

Storage & Stability

Store lyophilized peptide at –20°C

Protect from light, heat, and moisture

Reconstituted solutions should be handled using standard laboratory procedures

Each 3 mL vial is formulated with 10 mg of highly purified (>99%) lyophilized GLP-3 RT, produced in sterile environments that meet research-grade standards. Prime Peptides validates every batch through third-party laboratory testing to ensure exact molecular composition, stable peptide structure, and consistent results suitable for a wide range of experimental designs